Amgen Company Profile
| Company Name | Amgen |
|---|---|
| Website | https://www.amgen.com |
| Snippet | WebAmgen is a global biopharmaceutical company that develops and manufactures medicines for serious illnesses. Learn about its latest news, products, research, social … |
| ISIN | US0311621009 |
| Type | Public |
| Founded | 1980 |
| Revenue | US$ 23.4 billion (2019)[1][2] |
| Website | www.amgen.com |
| Formerly | Applied Molecular Genetics(1980–1983) |
| Industry | Biotechnology |
| Products | Aimovig, Aranesp, Blincyto, Epogen, Kineret, Enbrel, Kyprolis, Neulasta, Neupogen, Nplate, Parsabiv, Prolia, Repatha, Sensipar/Mimpara, Vectibix and Xgeva. |
| Traded as | NASDAQ: AMGNNASDAQ-100 ComponentS&P 100 ComponentS&P 500 ComponentSEHK: 4332 |
| Key people | Robert A. Bradway(Chairman, President, and CEO) |
| Net income | US$7.72 billion (2016) |
| Headquarters | Thousand Oaks, California, U.S. |
| Total assets | US$77.63 billion (2016) |
| Total equity | US$29.88 billion (2016) |
| Operating income | US$9.79 billion (2016)[3] |
| Number of employees | 22,000 (February 2020)[4] |
Amgen is part of the United States company list
Amgen is part of the Biotechnology company list
Have a list of company names and need to update information? Use our Company Search tool.
Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.
Want to update this profile? Please contact us here with a link to the public source verifying the edit.
Powrbot Inc. is a passionate company working on problems using data analytics, automation & machine learning. Our goal is to automate the boring stuff.
Contact Us
Email: contact@powrbot.com
